Study analyzes role of PARP enzyme in eukaryotes

Mar 08, 2011
Ohio State University’s Rebecca S. Lamb, Ph.D., co-authored a recent paper that used Ohio Supercomputer Center resources to conduct a phylogenetic analysis of a superfamily of enzymes implicated in a wide range of human diseases and important targets for anti-cancer therapies. Credit: Lamb/OSU

An Ohio State University molecular biologist leveraged a supercomputer to help better define the family tree of a group of enzymes that have been implicated in a wide range of human diseases and are important targets for anti-cancer therapies.

Along with several OSU colleagues, Rebecca S. Lamb, Ph.D., an assistant professor of , recently analyzed the of the poly(ADP-ribose) (PARP) superfamily.

These proteins are found in eukaryotes, a wide range of organisms – animals, plants, molds, fungi, algae and protozoa –whose cells contain complex structures enclosed within membranes. While PARP proteins can be found with any of these "supergroups," they have been most extensively studied in mammals.

"In these organisms, PARPs have key functions in DNA repair, genome integrity and epigenetic regulation," said Lamb. "More recently it has been found that proteins within the PARP superfamily have a broader range of functions that initially predicted."

The researchers used computers to identify 236 PARP proteins from 77 species across five of the six supergroups. Lamb then accessed the Glen Cluster at the Ohio Center (OSC) to perform extensive phylogenetic analyses of the identified PARP regions.

"This is computationally intensive work that would have been impossible without the computer resources provided at OSC," Lamb said. "In particular, the ability to try a variety of tools that require a great deal of CPU and memory capabilities was essential for success."

Amongst other tools, she employed the PhyML3.0 software package, which fit a statistical model to the aligned sequence data and provided estimates for the model's parameters.

"Dr. Lamb's project is an excellent example of a scientist running a very domain-specific software package on our state-of-the-art systems," said Ashok Krishnamurthy, Ph.D., interim co-executive director of OSC. "While the center maintains a large collection of licensed and open-source software, there are occasions where very specialized or customized applications are required. Our staff members are very good at working with researchers to modify these codes to get them installed, running and delivering results."

Access to powerful OSC systems allowed the researchers to experiment with a wide variety of options and parameters, in order to achieve the best results, Lamb noted.

"PARPs are found in all eukaryotic supergroups for which sequence is available, but some individual lineages within supergroups have independently lost these genes," said Lamb. "The PARP superfamily can be subdivided into six branches or 'clades.' Two of these clades were likely found in the last common eukaryotic ancestor. In addition, we have identified PARPs in organisms in which they have not previously been described."

Three main conclusions were drawn from the study. First, the broad distribution and pattern of representation of PARP genes indicated to the researchers that the ancestor of all existing eukaryotes encoded proteins of this type. Second, the ancestral PARP proteins had different functions and activities. One of these proteins likely functioned in DNA damage response. Third, the diversity of the PARP superfamily is larger than previously documented, suggesting as more eukaryotic genomes become available, this gene family will grow in both number and type.

Explore further: Two-armed control of ATR, a master regulator of the DNA damage checkpoint

More information: The study, "Evolutionary history of the poly(ADP-ribose) polymerase gene family in eukaryotes," appeared in a recent issue of the journal BMC Evolutionary Biology.

Provided by Ohio Supercomputer Center

4.5 /5 (2 votes)

Related Stories

Synthetic lethality: A new way to kill cancer cells

Feb 22, 2010

Ovarian and breast cancer treatments being developed that mix a protein inhibitor and traditional anticancer drugs are showing signs of success, according to a new review for Faculty of 1000 Biology Reports.

New test for ovarian cancer patients

Nov 09, 2010

Scientists have developed a new test to select which patients with ovarian cancer will benefit from new drugs called PARP inhibitors, according to research presented at the National Cancer Research Institute ...

Recommended for you

Japanese scientist resigns over stem cell scandal

Dec 19, 2014

A researcher embroiled in a fabrication scandal that has rocked Japan's scientific establishment said Friday she would resign after failing to reproduce results of what was once billed as a ground-breaking study on ...

'Hairclip' protein mechanism explained

Dec 18, 2014

Research led by the Teichmann group on the Wellcome Genome Campus has identified a fundamental mechanism for controlling protein function. Published in the journal Science, the discovery has wide-ranging implications for bi ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.